Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for China Pharma Holdings (CPHI) over the last 16 years, with Q3 2025 value amounting to $739733.0.

  • China Pharma Holdings' Non-Current Deferred Tax Liability fell 138.06% to $739733.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $739733.0, marking a year-over-year decrease of 138.06%. This contributed to the annual value of $731202.0 for FY2024, which is 147.04% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Non-Current Deferred Tax Liability is $739733.0, which was down 138.06% from $734246.0 recorded in Q2 2025.
  • China Pharma Holdings' 5-year Non-Current Deferred Tax Liability high stood at $827978.0 for Q1 2022, and its period low was $727417.0 during Q2 2023.
  • Over the past 5 years, China Pharma Holdings' median Non-Current Deferred Tax Liability value was $742114.0 (recorded in 2023), while the average stood at $762469.4.
  • In the last 5 years, China Pharma Holdings' Non-Current Deferred Tax Liability surged by 958.8% in 2021 and then crashed by 865.37% in 2022.
  • Quarter analysis of 5 years shows China Pharma Holdings' Non-Current Deferred Tax Liability stood at $824407.0 in 2021, then fell by 8.46% to $754698.0 in 2022, then decreased by 1.67% to $742114.0 in 2023, then fell by 1.47% to $731202.0 in 2024, then increased by 1.17% to $739733.0 in 2025.
  • Its Non-Current Deferred Tax Liability was $739733.0 in Q3 2025, compared to $734246.0 in Q2 2025 and $732241.0 in Q1 2025.